Answer
Women receiving fingolimod hydrochloride (Gilenya) should not breastfeed because of the potential for serious adverse reactions in nursing infants.
Sources for this answer
- Gilenya 0.25mg and 0.5mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 37Document updated
Sources checked